Varian Medical Systems to Present at Smith Barney Citigroup Small & Mid-Cap Conference in Las Vegas, NV | Varian

Varian Medical Systems to Present at Smith Barney Citigroup Small & Mid-Cap Conference in Las Vegas, NV

PALO ALTO, Calif., Feb. 10  /PRNewswire-FirstCall/ -- Varian MedicalSystems (NYSE: VAR) announced today that Spencer Sias, Vice President of
Investor Relations, will present at the Smith Barney Citigroup Small & Mid-Cap
Conference on February 16, 2005 at 1:05 p.m. at the Four Seasons at Mandalay
Bay, Las Vegas, NV.

    The presentation will be webcast and can be accessed at Varian Medical
Systems' web site at .

    Additional information on Varian Medical Systems may be obtained on the
company's website at

    Varian Medical Systems, Inc. of Palo Alto, California is the world's
leading manufacturer of integrated cancer therapy systems, which are used to
treat thousands of patients per day.  The company is also a premier supplier
of X-ray tubes and flat-panel digital subsystems for imaging in medical,
scientific, and industrial applications.  Varian Medical Systems employs
approximately 3,300 people who are located at manufacturing sites in North
America and Europe and in its 56 sales and support offices around the world.
In its most recent fiscal year ended October 1, 2004, Varian Medical Systems
reported sales of over $1.2 billion.  Additional information is available on
the company's investor relations web site at

    Forward Looking Statements

    This release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, including statements about
plans to hold a special stockholders meeting, mail a proxy statement to Varian
Medical Systems stockholders, and a vote by Varian Medical Systems
stockholders on a proposal to amend the company's restated certificate of
incorporation to increase the company's authorized shares of common stock.
Actual results might differ materially from these statements due to risks and
uncertainties, including those associated with the approval of the proposal by
Varian Medical Systems' stockholders; and changes in general economic,
business and industry conditions.  More complete descriptions of the risks
applicable to Varian Medical Systems appear in the company's documents filed
with the Securities and Exchange Commission and available on request from
Varian Medical Systems. Varian Medical Systems disclaims any intent or
obligation to update these forward-looking statements.


   Spencer Sias (650) 424-5782
   Vice President, Corporate Communications
   and Investor Relations

SOURCE: Varian Medical Systems, Inc.

Web site: